One, I understand your feelings about a buyback. I am not CEO, CFO, or a member of the board. I can offer opinions about and why the company is making decisions. My opinion holds no functional value. I do not know the total estimated expenses that will be necessary before the company is profitable. I assume that the decision makers do. Everyone on this forum knows that I was not in favor of giving this bunch full control of the company. My concern was mostly over a lack of experience with European drug launch. I don't have concerns about money management.
Sleven,
Market Data 
Markets 
AI
